4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-22-008814
CHIEF EXECUTIVE OFFICER bought 600,000 shares at $0.17 ($103,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2022-08-17 | Purchase | +600,000 | $0.17 | $103,200 | 626,234 | I |
| Open-market purchases · 600,000 sh · avg $0.17 · $103,200 | |||||||
Loading xslF345X03/form4-08182022_120836.xml…